Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Dec 7:41:101170.
doi: 10.1016/j.ymgmr.2024.101170. eCollection 2024 Dec.

A case study of lethal neonatal CPT II deficiency: Novel insights from genetic analysis

Thi Chi Mai Tran  1 , Van-Thao Ta  1 , Thi Bao Bui  2 , Chi Dung Vu  3 , Thuy Ngoc Pham  4
Affiliations
Case Reports

A case study of lethal neonatal CPT II deficiency: Novel insights from genetic analysis

Thi Chi Mai Tran et al. Mol Genet Metab Rep. .

Abstract

Introduction: Carnitine Palmitoyltransferase II (CPT II) deficiency encompasses a spectrum of disorders, with the lethal neonatal form (LNF) representing the rarest and most severe. While there are numerous CPT2 gene variants that can cause CPT II deficiency, only 16 variants of these are known to be associated with LNF. This report presents the case of a neonatal male diagnosed with lethal CPT II deficiency, characterized by the presence of two heterogeneous variants. Additionally, we provide a comprehensive review of all clinical symptoms, biochemistry, and reported pathogenic variants associated with LNF CPT II deficiency.

Case presentation: A neonatal male exhibited typical symptoms and biochemical features of CPT II deficiency, along with abnormal long-chain fatty acid profiles, notably an exceptionally high level of C18OH. Genetic analysis of the dried blood spot (DBS) sample revealed two heterozygous variants: CPT2 p.E174K and p.R554X. Both the healthy father and mother carried heterozygous variants, p.R554X and p.E174K, respectively.

Discussion: The symptoms of the LNF CPT II deficiency are characterized by the unavailability of fatty acids for energy production and the accumulation of lipids in tissues, primarily due to the extremely low activity of CPT II. The genetic variants associated with these cases are notably limited, and all of them are classified as 'severe' variants. In the presented case, the co-occurrence of p.R554X with another severe variant, p.E174K, manifests as LNF, this compelling evidence strongly supports the assertion that p.R554X is a potentially severe pathogenic variant contributing to CPT II deficiency.

Conclusion: This report represents the initial documentation of a LNF CPT II deficiency case characterized by the presence of two heterozyous CPT2 variants: p.E174K and p.R554X. As a result, the p.R554X variant is potentially classified as a severe pathogenic variant. It further emphasizes the significance of early detection and precise mutation classification for effective disease.

Keywords: CPT II deficiency; CPT2; E174K; Lethal neonatal form; R554X.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Wieser T., Deschauer M., Olek K., Hermann T., Zierz S. Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients. J. Neurol. Apr 22, 2003;60(8):1351–1353. - PubMed
    1. Gellera C., Witt D.R., Verderio E., Cavadini P., DiDonato S., Taroni F. Molecular study of lethal neonatal carnitine palmitoyltransferase II (CPT II) deficiency. (Abstract) Am. J. Hum. Genet. 1992;51(suppl) p. A168 only.
    1. Elpeleg O.N., Hammerman C., Saada A., Shaag A., Golzand E., Hochner-Celnikier D., Berger I., Nadjari M. Antenatal presentation of carnitine palmitoyltransferase II deficiency. Am. J. Med. Genet. Aug 1, 2001;102:183–187. 2. - PubMed
    1. Vladutiu G.D., Quackenbush E.J., Hainline B.E., Albers S., Smail D.S., Bennett M.J. Lethal neonatal and severe late infantile forms of carnitine palmitoyltransferase II deficiency associated with compound heterozygosity for different protein truncation mutations. J. Pediatr. 2002;141(5):734–736. - PubMed
    1. Isackson P.J., Bennett M.J., Lichter-Konecki U., Willis M., Nyhan W.L., Sutton V.R., Tein I., Vladutiu G.D. CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency. Mol. Genet. Metab. 2008;94(4):422–427. - PubMed

Publication types

LinkOut - more resources